CLS

Analyst Note: Celestica Inc. (CLS)

Date: 2026-06-13 Price: $372.55

1. Structural Readiness

• State: Forming
• Conservative Entry: — (Not yet triggered; requires a confirmed breakout above the forming coil resistance).
• Aggressive/Pre-Breakout Entry: — (Not actionable on its own; requires confirmation).
• Breakout Level: — (Not yet fired).
• Current Price: $372.55.
• Extension: — (No extension data provided relative to a breakout level).
• ATR Context: Current ATR is 7.3% (Very High). This indicates elevated volatility, which is consistent with a high-growth name in a secular boom but requires careful position sizing.

2. Thesis Layer

• Primary Secular Theme: AI Infrastructure (Datacenter Capex / Servers).
• Directness: Tier Direct.
• Exposure Analysis: CLS is a primary beneficiary of the AI Infrastructure wave. The company is not merely a peripheral supplier but a core manufacturing and design partner for hyperscalers. The evidence points to a direct correlation between the company's revenue growth and the capital expenditure cycles of major cloud service providers (hyperscalers) building out AI-specific infrastructure.
• Additional Tailwinds: While the primary driver is AI, the company also benefits from the broader "Cloud-based and other service providers" shift, which is cyclically distinct from traditional OEM cycles. The company is also exposed to the "Enterprise" AI/ML compute ramp, though this is secondary to the hyperscaler dominance.

3. Business Overview

Celestica Inc. operates as a comprehensive hardware platform and supply chain solutions provider, delivering services from initial design and engineering to manufacturing, assembly, and logistics. The company operates through two key segments: Advanced Technology Solutions and Connectivity & Cloud Solutions (CCS).

• Business Model: The company generates revenue by designing, manufacturing, and integrating complex hardware infrastructure for clients, primarily hyperscalers and OEMs.
• Industry: Technology / Electronics Manufacturing Services (EMS) / AI Infrastructure.
• Key Evidence (as of 2026-06-13):
• Revenue Growth: In Q1 2026, the company raised its full-year revenue outlook from $17 billion to $19 billion, representing 53% growth. The CCS segment alone is anticipated to see 70% revenue growth for 2026.
• Segment Performance: The CCS segment revenue increased 76% in Q1 2026 compared to Q1 2025, driven by strong demand for 800G networking switches and AI compute programs. The HPS (Hyperscale) revenue increased 63% in Q1 2026 to $1.7 billion, now accounting for 42% of total revenue.
• Margin Expansion: Management expects an adjusted operating margin of 8.1% for 2026, an improvement from the previous outlook of 7.8%.
• Strategic Wins: The company secured a landmark program award for the design and manufacturing of a 1.6T, co-packaged optics Ethernet switch with a hyperscaler. Mass production is expected to commence in 2027.
• Customer Concentration: The top 10 customers represented 79% of total revenue in 2025. Three customers in the CCS segment individually represented 10% or more of total revenue (32%, 14%, and 12%).
• Capital Allocation: Management anticipates 2026 capital expenditures to increase compared to 2025 to support this growth.

4. Archetype and Conviction

• Archetype: Growth Leader.
• Fit: The company fits the Growth Leader archetype due to its double-digit revenue growth, expanding margins, and leadership in the high-growth AI infrastructure sector. The shift in revenue mix toward hyperscalers (cyclically different from traditional OEMs) reinforces this classification.
• Valuation Context: Forward consensus EPS for FY1 is $10.08 and FY2 is $14.96. The company is trading at a premium multiple consistent with a high-growth leader in a secular boom, but the earnings trajectory supports the valuation if execution continues.
• Conviction Stack:
• Thesis Strength: High. The AI Infrastructure thesis is the dominant secular theme, and CLS is a direct beneficiary.
• Evidence Quality: Strong. Multiple earnings transcripts and SEC filings confirm the revenue ramp, margin expansion, and specific program wins (1.6T switch).
• Structural Quality: High. The company is successfully executing complex next-generation designs (co-packaged optics) and has secured long-term programs.
• Setup Readiness: Moderate (Forming). The technical setup is in a "forming" state. While the fundamental story is strong, the price action has not yet confirmed a breakout above the resistance structure. The "Very High" ATR (7.3%) suggests volatility that could lead to false breakouts or deep pullbacks before a sustained move.
• Rerating Potential: Significant. As the company transitions from a traditional EMS to a high-value design and manufacturing partner for AI, the market may re-rate the stock based on the higher margin profile and growth sustainability.

5. Invalidations, Strengtheners, and Gaps

• Invalidation Factors:
• A significant reduction in guidance or a miss on the 2026 revenue/earnings outlook (currently $19B revenue, $10.15 EPS).
• A slowdown in hyperscaler capex or a delay in the 1.6T switch program ramp.
• Strengtheners:
• Confirmation of the 1.6T switch program ramp in 2027.
• Continued margin expansion beyond the 8.1% target.
• Diversification of the top 10 customer concentration (currently 79%).
• Gaps in Evidence:
• Customer Specifics: While the top 10 customers are identified by revenue share, the specific names of the top 3 CCS customers (beyond the general "hyperscaler" label) are not explicitly named in the provided evidence, though Amazon, Meta, and Google are listed as CCS customers in the 2025 filing.
• Capex Details: While capex is expected to increase, the specific dollar amount or allocation breakdown is not detailed.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: High Key evidence: Raised 2026 revenue outlook to $19B (53% growth) and EPS to $10.15 (68% growth); secured landmark 1.6T co-packaged optics switch program with hyperscaler; CCS segment revenue up 76% in Q1 2026. Key risks: High customer concentration (top 10 customers = 79% of revenue); Very High ATR (7.3%) indicating elevated volatility and potential for sharp pullbacks; dependence on hyperscaler capex cycles. Sizing hint: Moderate position size due to forming technical setup and high volatility; scale in on confirmed breakout. Expected path: Management expects continued revenue ramp and margin expansion; structural implication is a shift to higher-value design/manufacturing mix with 1.6T production starting 2027. Expected horizon: 12-18 months for the thesis to fully play out as 1.6T programs ramp.